MedTrace Logo

LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology

NCT05184790 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-05-19

No results posted yet for this study

Summary

This study will develop a whole-of-body markerless tracking method for measuring the motion of the tumour and surrounding organs during radiation therapy to enable real-time image guidance.

Routinely acquired patient data will be used to improve the training, testing and accuracy of a whole-of-body markerless tracking method. When the markerless tracking method is sufficiently advanced, according to the PI of each of the data collection sites, the markerless tracking method will be run in parallel to, but not intervening with, patient treatments during data acquisition.

Conditions

Sponsors & Collaborators

  • Princess Alexandra Hospital, Brisbane, Australia

    collaborator OTHER

  • Calvary Mater Newcastle, Australia

    collaborator OTHER

  • Western Sydney Local Health District

    collaborator OTHER

  • Austin Health

    collaborator OTHER_GOV

  • Peter MacCallum Cancer Centre, Australia

    collaborator OTHER

  • University of Sydney

    lead OTHER

Principal Investigators

  • Paul Keall · Professor

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-28
Primary Completion
2028-01-31
Completion
2028-01-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05184790 on ClinicalTrials.gov